Abstract

Osteoarthritis and sarcopenia are two major joint and skeletal muscle diseases prevalent during aging. Osteoarthritis is a multifactorial progressive degenerative and inflammatory disorder of articular cartilage. Cartilage protection and pain management are the two most important strategies in the management of osteoarthritis. Sarcopenia, a condition of loss of muscle mass and strength, is associated with impaired neuromuscular innervation, the transition of skeletal muscle fiber type, and reduced muscle regenerative capacity. Management of sarcopenia requires addressing both skeletal muscle quantity and quality. Emerging evidence suggests that green tea catechins play an important role in maintaining healthy joints and skeletal muscle. This review covers (i) the prevalence and etiology of osteoarthritis and sarcopenia, such as excessive inflammation and oxidative stress, mitochondrial dysfunction, and reduced autophagy; (ii) the effects of green tea catechins on joint health by downregulating inflammatory signaling mediators, upregulating anabolic mediators, and modulating miRNAs expression, resulting in reduced chondrocyte death, collagen degradation, and cartilage protection; (iii) the effects of green tea catechins on skeletal muscle health via maintaining a dynamic balance between protein synthesis and degradation and boosting the synthesis of mitochondrial energy metabolism, resulting in favorable muscle homeostasis and mitigation of muscle atrophy with aging; and (iv) the current study limitations and future research directions.

Highlights

  • Sarcopenia, a progressive neuromuscular disorder causing a reduction in skeletal muscle mass and strength in the elderly, is associated with morbidity, metabolic dysregulation, functional disability, poor daily activity function, and mortality [4,5,6]

  • We summarize the state of knowledge of laboratory preclinical research and limited human studies assessing the effects of green tea and epigallocatechin gallate (EGCG) on joint and skeletal muscle, along with a discussion of future directions in translational research

  • Babu et al incubated C2C12 pretreated with Green Tea Extract (GTE) (40–160 μM) with 100 μM citrinin (ROS inducer), which showed a suppression of the lactate dehydrogenases, an increase in cell viability, and the protection of myotube from ROS-induced damage [95]

Read more

Summary

Introduction

Prevalence of Osteoarthritis and Sarcopenia Osteoarthritis (OA) and sarcopenia (SC), two major aging-related joint and skeletal muscle diseases, are prevalent among the elderly population and interact closely during the complex biological process of aging. Knee OA, a progressive joint disease characterized by the degeneration and inflammation of joints [1,2], is among the five leading causes of disability [3]. Around 70 million Americans are at risk of OA and the financial expenditure for OA care is estimated to be $15.5–$28.6 billion per year in 2030 [3]. Sarcopenia, a progressive neuromuscular disorder causing a reduction in skeletal muscle mass and strength in the elderly, is associated with morbidity, metabolic dysregulation, functional disability, poor daily activity function, and mortality [4,5,6]. Alleviating the pain and mitigating pain-related dysfunction in patients with knee OA as well as slowing the process of SC-associated disorders are public health priorities

Etiology of Osteoarthritis and Sarcopenia
Osteoarthritis
Sarcopenia
Green Tea
Cell and Tissue Explant Studies
Animal Studies
Human Studies
In Vitro Studies
Rodent Studies
Effect of GTE on Inflammation of Skeletal Muscle Animal studies
Effect of GTE on Autophagy in Skeletal Muscle
Findings
Effect of GTE on Mitochondria-Related Metabolism in Skeletal Muscle
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call